Submitting.
She was then instrumental in the company integration and broader CLS services strategy in her vice-president role.
Clare Doris and Clare Wareing of Cumulus Oncology, which is based in Edinburgh. Picture: Stewart Attwood
Clare Wareing, chief executive and co-founder of Cumulus Oncology, said: “In her role at Aquila, Clare was instrumental in transforming the company from a start-up to a successful specialist service provider, while leading collaborations supporting value creation and fundraising efforts for a range of biotech companies.
“This kind of experience is a great fit for where we are at on the Cumulus journey, with our own plans to scale the business over the next few years.”
Questor Inheritance Tax Portfolio: HM Treasury knows business property relief is too generous and will act soon
5 March 2021 • 5:00am
Another Budget has passed and it is another sigh of relief for followers of Questor’s Inheritance Tax Portfolio. The rules underpinning its existence have been left untouched.
The idea of business property relief being abolished, or at least changed, gathered momentum in 2020. However, as the world changed so did the Chancellor’s plans. Questor did not expect such generosity this time. It would be wise to assume this will not last for long.
Business property relief, in its current form, is generous and the Government knows this. The Alternative Investment Market (Aim) has changed and now has several multinational and £1bn-plus companies, not small plucky upstarts the relief was aimed at.
No strategy to Sunak marking his own homework on industry | Budget 2021 theguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theguardian.com Daily Mail and Mail on Sunday newspapers.
Cumulus Oncology eyes new hires and US office opening in 2021
Edinburgh-based drug discovery accelerator also seeking further venture capital backing for growth
Sign up to FREE email alerts from
businessInsider -
Subscribe
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You can unsubscribe at any time.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
Drug discovery accelerator Cumulus Oncology is eyeing global alliances, venture capital partnerships and a US office opening in 2021.